Spero Therapeutics Inc.
SPRO
|
|
| |
|
| Trading Volume | 5,577 |
|
|
1.81 - 1.00 |
| Market Cap Full | $ 72.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 6.8% | 17% | -16.2% | -45.7% |
| Q2 | - | -26% | - | -91.5% |
| Q3 | - | -2.1% | -16.6% | 169.9% |
| Q4 | - | -9.7% | 23.5% | -13.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 3.4 | 8.6 | 4.2 | -18.6 | 1.4 | -5.6 | 4.5 | -2.1 | - | - | - | - |
| 2023 | |||||||||||
| 6.9 | -20 | -2 | 22.1 | -1.7 | -16.7 | 12.4 | -8 | -19.3 | -10.7 | 5.6 | 29 |
| 2022 | |||||||||||
| -27.4 | -17.4 | -9.4 | -44.1 | -75.7 | -37.2 | -1.2 | 18.3 | 131 | -2 | -1 | -10.8 |
| 2021 | |||||||||||
| -6.6 | 0.3 | -19 | -6.7 | 6.9 | -4.9 | -3.9 | 43.4 | -4.4 | -4.6 | -18.6 | 12 |
| 2020 | |||||||||||
| 1.1 | 3.6 | -15.3 | 53.8 | -4.9 | 14.5 | -13.5 | -7.1 | 2.7 | 17.4 | 26.7 | 16.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -1 | -0.7 | -1.2 |
| Q2 | -0.2 | -0.9 | -0.6 | -0.9 |
| Q3 | -0.1 | -0.3 | -0.7 | -0.9 |
| Q4 | 0 | 1 | -0.9 | -0.6 |
| A | -0.54 | -1.2 | -2.9 | -3.5 |